Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidate
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
-
-
SIGA Technologies announced Department of Defense increased funding to develop Post Exposure prophylactic indication for TPOXX
On Jun. 15, 2020, SIGA Technologies announced that it had been awarded a multi-year contract from the United…
-
Immunic announced first patients dosed in its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
-
Cleveland Clinic researchers developed first model to predict likelihood of testing positive for COVID-19 and outcomes from the disease
On Jun. 15, 2020, Cleveland Clinic researchers announced have developed the world’s first risk prediction model for healthcare…
-
WHO reported cluster of COVID-19 in Beijing, China
On Jun. 13, 2020, the World Trade Organization (WTO) reported that it was following up with Chinese authorities…
-
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
On Jun. 13, 2020, AstraZeneca announced it had reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded…
-
Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir
On Jun. 13, 2020, Dr. Reddy’s Laboratories announced that it had entered into a non-exclusive Licensing Agreement with Gilead…
-
Sinovac announced positive preliminary results of phase I/II clinical trials for inactivated vaccine candidate against COVID-19
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Company’s…
-
Biotechnology | FDA | HIV | Therapeutics
ViiV Healthcare announced FDA approval of the first-ever dispersible tablet formulation of dolutegravir for children living with HIV
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
-
Biotechnology | FDA | Oncology | Vaccine
FDA approved HPV vaccine Gardasil as throat cancer prevention
On Jun. 12, 2020, the Food and Drug Administration (FDA) announced it had approved an expanded indication for…
-
Mutated coronavirus shows significant boost in infectivity
On Jun. 12, 2020, a tiny genetic mutation in the SARS coronavirus 2 variant circulating throughout Europe and…
-
CIRM board approved two additional COVID-19 projects
On Jun. 12, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two additional…
-
Cue Health received FDA EUA for Its rapid, portable, molecular point-of-care COVID-19 test
On Jun. 12, 2020, Cue Health announced that it had received Emergency Use Authorization from the U.S. Food…
-
Biotechnology | CDC | FDA | HIV | Therapeutics
The FDA approved drug to treat infants and children with HIV
On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD…
-
Brain cells can harbor and spread HIV virus to the body
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
-
Oldest relative of ragworms and earthworms discovered
On Jun. 11, 2020, scientists at the Universities of Oxford, Exeter, Yunnan and Bristol announced they had discovered…
-
Sinovac and Butantan joined efforts to advance clinical development of an inactivated vaccine for COVID-19 to phase III
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
-
Emergent BioSolutions signed agreement to be US manufacturing partner for AstraZeneca’s COVID-19 vaccine candidate
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
-
Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
-
AIM ImmunoTech filed provisional patent application for ose of Ampligen(R) as potential therapy for COVID-19 Induced chronic fatigue
On Jun. 11, 2020, AIM ImmunoTech announced that it had filed a provisional patent application for, among other…
-
Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
-
Innovation Pharma collaborated with regional biocontainment lab on grant application to research Brilacidin as pan-Coronavirus therapeutic
On Jun. 11, 2020, Innovation Pharma and researchers at a U.S. Regional Biocontainment Laboratory (RBL) announced they are…
-
Regeneron began first clinical trials of anti-viral antibody cocktail REGN-COV2 for treatment and prevention of COVID-19
On Jun. 11, 2020, Regeneron announced announced that Science has accepted for publication two papers describing the creation of…
-
Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants
On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
-
UT Southwestern scientists examined structure of protein involved in Parkinson’s disease, psychosis and addiction
On Jun. 11, 2020, a study led by UT Southwestern researchers revealed the structure of the active form…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Therapeutics
InBios received FDA Emergency Use Authorization for COVID-19 antibody test
On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
-
Atossa Therapeutics announced availability of manuscript on results from in vitro testing of COVID-19 drug
On Jun. 11, 2020, Atossa Therapeutics announced that the manuscript of the results from in vitro testing of AT-H201, Atossa’s…
-
NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe disease
On Jun. 11, 2020, a team of researchers from the National Library of Medicine identified genomic features of…
-
Biotechnology | FDA | Medicine | Oncology | Pharmaceutical | Radiology | Therapeutics
FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinoma
On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo ® (nivolumab) was approved by the U.S. Food and…
-
NIH scientists developed blood test to help improve liver cancer screening
On Jun. 11, 2020, scientists at the National Cancer Institute (NCI) announced they have developed a new test…
